BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3562454)

  • 1. The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper.
    Brewer GJ; Hill G; Prasad A; Dick R
    Proc Soc Exp Biol Med; 1987 Apr; 184(4):446-55. PubMed ID: 3562454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
    Dastych M; Procházková D; Pokorný A; Zdrazil L
    Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
    Veen C; van den Hamer CJ; de Leeuw PW
    J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilson's disease: assessment of D-penicillamine treatment.
    Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
    Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
    Martins da Costa C; Baldwin D; Portmann B; Lolin Y; Mowat AP; Mieli-Vergani G
    Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
    Brewer GJ; Dick RD; Johnson VD; Brunberg JA; Kluin KJ; Fink JK
    J Lab Clin Med; 1998 Oct; 132(4):264-78. PubMed ID: 9794697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral zinc sulphate for Wilson's disease.
    Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
    Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose zinc administration as an effective Wilson's disease treatment.
    Najda J; Stella-Hołowiecka B; Machalski M
    Biol Trace Elem Res; 2001 Jun; 80(3):281-4. PubMed ID: 11508632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients.
    Ince AT; Kayadibi H; Soylu A; Ovunç O; Gültepe M; Toros AB; Yaşar B; Kendir T; Abut E
    Dig Dis Sci; 2008 Jun; 53(6):1564-72. PubMed ID: 17934856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY
    J Am Coll Nutr; 1990 Oct; 9(5):487-91. PubMed ID: 2258535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic anemia of Wilson's disease.
    Iser JH; Stevens BJ; Stening GF; Hurley TH; Smallwood RA
    Gastroenterology; 1974 Aug; 67(2):290-3. PubMed ID: 4847708
    [No Abstract]   [Full Text] [Related]  

  • 18. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
    Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
    Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
    [No Abstract]   [Full Text] [Related]  

  • 19. Wilson's disease: current status.
    Yarze JC; Martin P; Muñoz SJ; Friedman LS
    Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.